A study evaluating effect of everolimus on perfusional parameters in pancreatic neuroendocrine tumour patients with liver metastases
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Liver metastases; Neuroendocrine tumours; Pancreatic cancer
- Focus Therapeutic Use
- 10 Oct 2017 New trial record